[{"Assets_0_Q3_USD":152611000.0,"CommonStockSharesOutstanding_0_Q3_shares":34554000.0,"EarningsPerShareBasic_3_Q3_USD":-0.03,"EarningsPerShareBasic_1_Q3_USD":0.04,"EarningsPerShareDiluted_3_Q3_USD":-0.03,"EarningsPerShareDiluted_1_Q3_USD":0.04,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":13629000.0,"NetIncomeLoss_3_Q3_USD":-1098000.0,"NetIncomeLoss_1_Q3_USD":1325000.0,"StockholdersEquity_0_Q3_USD":132101000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":34314000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":37654000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":34314000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":34472000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20171108"}]